| Hans-Günter Meyer-Thompson | Buprenorphin
Investigating outcomes in a substance use treatment provider: a cross-sectional comparison of long-acting injectable buprenorphine and oral medication for opioid use disorder
Investigating outcomes in a substance use treatment provider: a cross-sectional comparison of long-acting injectable buprenorphine and oral medication for opioid use disorder
Montgomery C, Abbasi Y, De Silva D, Gittins R, Jones A, Van Hout MC.
BMJ Open. 2025 Feb 18;15(2):e090736. doi: 10.1136/bmjopen-2024-090736. PMID: 39965956; PMCID: PMC11836814.